Table 2

Clinical parameters of HIV-infected subject cohorta

Patient group and identifierViral load (RNA copies/ml)ART statusCD4 count (cells/ml)AgeGenderHLA type(s)SL9 responseKF11 responseNV9 response (% tetramer+)
SFU/million cells% tetramer+SFU/million cells% tetramer+
EC 1655<50Naïve1,74145FA2, B57901.07701.761.4
EC 5823<50Naïve89051MA2, B572,2853.792,8152.592.84
EC 5915b178Naïve85044MA22600.18NANAND
ST 4081<50On62359MA21050.52NANA3.43
ST 3814<50On57660FA2, B571,0001.861,0001.581.84
ST 4447<50On45852MA2, B571,0001.271,0001.99ND
ST 4480<50On55031MB57NANA4501.59NA
ST 4496<50On57351FA23100.51NANAND
VC 2795c<50Off40448MB57NANA4,2654.12NA
VC 2976453Naïve86337FB57NANA1250.37NA
VC 4311873Naïve52447MA23371.56NANAND
VC 6351955Naïve64239MB57NANA6802.22NA
P 64101,728Naïve84727FA2, B570.887151.17ND
P 40245,258Naïve28934MA2, B573000.413100.83ND
P 444712,768Naïve50152MA2, B571,3201.272,6501.87ND
P 449614,208Off26051FA23101.42NANA0.88
P 408141,681Off43659MA21050.6NANA3.21
P 631543,500Naïve57139MB57NANA6802.02NA
P 256953,876Off40642MA2, B570.361,0583.150.62
P 448065,030Off42431MB57NANA4503.11NA
P 408168,139Naïve40859MA21050.44NANA3.24
P 158179,286Naïve67241MA2, B571.43301.931.72
P 4480264,120Off29431MB57NANA4501.48NA
  • a SFU, spot-forming units; F, female; M, male; NA, data not available (individual did not have the HLA allele restricting the specific peptide tested); —, response not detected (<50 SFU/million cells); ND, not done.

  • b Patient had viral blip of 178 copies/ml.

  • c All prior viral load measurements ranged from 81 to 458 copies/ml.